Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,900 | 391 | 94.5% |
| Education | $461.53 | 14 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,274 | 70 | $0 (2024) |
| Janssen Biotech, Inc. | $990.65 | 50 | $0 (2024) |
| PFIZER INC. | $561.90 | 39 | $0 (2024) |
| ABBVIE INC. | $529.72 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $483.83 | 24 | $0 (2024) |
| Amgen Inc. | $434.41 | 21 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $425.40 | 10 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $380.96 | 14 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $327.33 | 13 | $0 (2024) |
| Aytu Bioscience, Inc | $313.19 | 23 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,092 | 39 | C. R. Bard, Inc. & Subsidiaries ($258.52) |
| 2023 | $1,077 | 41 | Sumitomo Pharma America, Inc. ($198.15) |
| 2022 | $707.96 | 27 | Progenics Pharmaceuticals, Inc. ($99.80) |
| 2021 | $892.35 | 42 | Amgen Inc. ($123.53) |
| 2020 | $509.17 | 29 | Bayer HealthCare Pharmaceuticals Inc. ($97.42) |
| 2019 | $1,265 | 66 | Astellas Pharma US Inc ($253.14) |
| 2018 | $1,531 | 93 | Janssen Biotech, Inc. ($298.32) |
| 2017 | $1,287 | 68 | Astellas Pharma US Inc ($264.85) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Urology | ||||||
| 12/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Oncology | ||||||
| 10/05/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $25.84 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 08/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Oncology | ||||||
| 07/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: UROLOGY | ||||||
| 06/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 05/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Urology | ||||||
| 03/15/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,671 | 6,552 | $542,957 | $160,970 |
| 2022 | 26 | 2,706 | 4,753 | $598,624 | $169,298 |
| 2021 | 22 | 2,761 | 4,793 | $587,544 | $180,105 |
| 2020 | 21 | 2,970 | 4,740 | $576,771 | $176,712 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 768 | 1,131 | $226,200 | $74,295 | 32.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 28 | 210 | $103,950 | $28,003 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 161 | $40,250 | $15,646 | 38.9% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 113 | 131 | $22,925 | $6,108 | 26.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 35 | 122 | $22,570 | $5,829 | 25.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 24 | 81 | $14,175 | $5,124 | 36.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 419 | 578 | $28,900 | $4,922 | 17.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 19 | 24 | $12,000 | $4,818 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $9,860 | $4,745 | 48.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 744 | 1,110 | $27,750 | $2,428 | 8.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 24 | $4,800 | $1,671 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 152 | 171 | $4,275 | $1,436 | 33.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $7,200 | $1,184 | 16.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 27 | 41 | $3,075 | $1,026 | 33.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 22 | $3,300 | $903.54 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 17 | $1,445 | $765.12 | 52.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 75 | $4,500 | $730.77 | 16.2% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 16 | 18 | $2,250 | $493.48 | 21.9% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 18 | 109 | $763.00 | $467.44 | 61.3% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 25 | 87 | $870.00 | $184.26 | 21.2% |
| J1644 | Injection, heparin sodium, per 1000 units | Office | 2023 | 18 | 731 | $1,462 | $140.04 | 9.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $420.00 | $40.92 | 9.7% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 1,651 | $16.51 | $9.82 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 786 | 1,091 | $218,200 | $72,220 | 33.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 40 | 304 | $150,480 | $41,430 | 27.5% |
About Dr. Michael Flanagan, M.D
Dr. Michael Flanagan, M.D is a Urology healthcare provider based in Middlebury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902860166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Flanagan, M.D has received a total of $8,362 in payments from pharmaceutical and medical device companies, with $1,092 received in 2024. These payments were reported across 405 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,900).
As a Medicare-enrolled provider, Flanagan has provided services to 11,108 Medicare beneficiaries, totaling 20,838 services with total Medicare billing of $687,084. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Middlebury, CT
- Active Since 04/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1902860166
Products in Payments
- XTANDI (Drug) $1,023
- Natesto (Drug) $507.79
- PROVENGE (Drug) $442.50
- Bard Urinary Drainage Bag (Device) $406.13
- Erleada (Drug) $379.69
- ERLEADA (Drug) $371.61
- Nubeqa (Drug) $307.72
- Prolia (Biological) $291.69
- GEMTESA (Drug) $254.46
- PYLARIFY (Drug) $241.86
- ZYTIGA (Drug) $239.35
- Xtandi (Drug) $231.35
- ORGOVYX (Drug) $217.50
- ELIGARD (Drug) $209.34
- Lupron (Drug) $186.73
- Xofigo (Drug) $176.11
- MYRBETRIQ (Drug) $144.23
- JEVTANA (Drug) $143.10
- XIAFLEX (Biological) $134.79
- GENERAL ERECTILE DYSFUNCTION (Device) $119.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Middlebury
York Moy, M.d, M.D
Urology — Payments: $19,679
Anthony Kim, M. D, M. D
Urology — Payments: $14,108
Sagar Phatak, M. D, M. D
Urology — Payments: $11,014
Joseph Antoci, M. D, M. D
Urology — Payments: $100.28
Robert Feldman, M.d, M.D
Urology — Payments: $83.85